Moderna
MRNA
#1188
Rank
S$21.31 B
Marketcap
$55.39
Share price
0.79%
Change (1 day)
-60.56%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -S$3.16 Billion

According to Moderna 's latest financial reports the company's current earnings are S$5.05 Billion. In 2023 the company made an earning of -S$5.27 Billion a decrease over its 2022 earnings that were of S$12.96 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$3.16 Billion-40.11%
2023 -S$5.27 Billion-140.65%
2022 S$12.96 B-27.81%
2021 S$17.95 B-1911.15%
2020 -S$1 Billion44.7%
2019 -S$0.69 Billion28.63%
2018 -S$0.54 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$55.84 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
S$20.20 B-742.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$56.37 Million-98.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.26 Billion-91.98%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.18 B-646.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-S$0.79 Billion-75.09%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.82 B-889.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.16 Billion-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA